Centers & Institutes

Although the Neurofibromatosis Therapeutic Acceleration Program (NTAP) is housed at Johns Hopkins University, we fund innovative investigators at research centers and institutes around the world. We continuously seek out individuals with the creativity and expertise required to develop therapies for plexiform neurofibromas (pNFs) and cutaneous neurofibromas (cNFs), recruiting the most skilled investigators to our network.

Our partners include:

  • BioBasix, Inc.
  • Brigham and Women’s Hospital
  • Case Western Reserve University School of Medicine
  • Children’s Hospital of Philadelphia
  • Children’s National Health System
  • Children’s National Medical Center
  • Cincinnati Children’s Hospital
  • DoD
  • Galen, UK
  • Harvard University
  • Iconcologia
  • Indiana University
  • Innocentive
  • INSERM
  • Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Spain
  • Memorial Sloan Kettering Cancer Center
  • Michigan State University College of Human Medicine
  • National Cancer Institute (NCI)
  • Northwestern University
  • Padova University
  • Rainbow Babies and Children’s Hospital
  • Riley Hospital for Children
  • SAGE Bionetworks
  • Spectrum Health Medical Group
  • The Brain Science Institute (BSi)
  • The Childhood Brain Tumor Foundation
  • The Children’s Tumor Foundation (CTF)
  • The European Medical Administration (EMA)
  • The FDA, Drug Development Tools (DDTs) Qualification Program
  • The NIH National Center for Advancing Translational Sciences (NCATS)
  • The NIH Office of Rare Diseases
  • The US Food and Drug Administration (FDA)
  • The Pediatric Oncology Branch of the National Cancer Institute (POB-NCI)
  • UCSF
  • UCLA
  • University of Alabama
  • University of Chicago
  • University of Florida
  • University of Manchester
  • University of Michigan
  • University of Milan
  • University of Tirkku
  • UT Southwestern
  • Van Andel Institute
  • Washington University
  • Wayne State University